ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PTN Palatin Technologies Inc New

1.827
0.107 (6.22%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Palatin Technologies Inc New PTN AMEX Common Stock
  Price Change Price Change % Share Price Last Trade
0.107 6.22% 1.827 19:00:00
Open Price Low Price High Price Close Price Previous Close
1.72 1.68 1.83 1.82 1.72
more quote information »

Recent News

Date Time Source Heading
4/08/202406:30PRNUSPalatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease..
3/07/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202411:57EDGAR2Form 144 - Report of proposed sale of securities
2/28/202406:30PRNUSPalatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3..
2/15/202408:00EDGAR2Form 8-K - Current report
2/15/202406:30PRNUSPalatin Reports Second Quarter Fiscal Year 2024 Financial..
2/14/202415:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/14/202413:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/09/202406:30PRNUSPalatin to Report Second Quarter Fiscal Year 2024 Results;..
2/05/202406:30PRNUSPalatin Announces Database Lock for PL9643 MELODY-1 Pivotal..
2/01/202416:16EDGAR2Form 8-K - Current report
2/01/202415:00PRNUSPalatin Announces Closing of $10 Million Registered Direct..
1/30/202407:00PRNUSPalatin Announces $10 Million Registered Direct Offering
1/08/202409:33PRNUSPalatin Provides Corporate Update and Highlights Strategic..
1/03/202407:00BWCosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide..
12/20/202308:00EDGAR2Form 8-K - Current report
12/20/202306:30PRNUSPalatin Completes Sale of Vyleesi® to Cosette..
12/18/202315:45EDGAR2Form 8-K - Current report
12/18/202315:15PRNUSPalatin Receives Notice of Acceptance of the Listing..
12/17/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
12/08/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/06/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/06/202313:25EDGAR2Form 144 - Report of proposed sale of securities
12/04/202316:00EDGAR2Form S-1 - General form for registration of securities under..
12/01/202314:52EDGAR2Form 144 - Report of proposed sale of securities
11/14/202306:30PRNUSPalatin Reports First Quarter Fiscal Year 2024 Financial..
11/09/202306:30PRNUSPalatin to Report First Quarter Fiscal Year 2024 Results;..
10/24/202315:50PRNUSPalatin Announces Closing of $5 Million Registered Direct..
10/24/202315:05EDGAR2Form 8-K - Current report
10/23/202306:30PRNUSPalatin Announces $5 Million Registered Direct Offering
10/19/202307:01EDGAR2Form 8-K - Current report
10/19/202306:30PRNUSPalatin Announces Preliminary Quarter Ended September 30,..
10/18/202306:30PRNUSPalatin Announces Positive Preclinical Data Showing..
10/16/202306:30PRNUSPalatin Presents Data at the United European..
10/13/202315:31EDGAR2Form 8-K - Current report
10/13/202315:15PRNUSPalatin Receives Notice of Non-Compliance from NYSE American
9/28/202307:02EDGAR2Form 8-K - Current report
9/28/202307:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
9/28/202306:30PRNUSPalatin Reports Fourth Quarter and Fiscal Year Ended 2023..
9/22/202315:00PRNUSPalatin to Report Fourth Quarter and Fiscal Year End 2023..
9/08/202307:00EDGAR2Form 8-K - Current report
9/07/202315:00PRNUSPalatin to Present at the H.C. Wainwright 25th Annual Global..
9/07/202307:49EDGAR2Form 8-K - Current report
9/07/202306:30PRNUSPalatin Completes Enrollment in Phase 3 MELODY-1 Study of..
8/16/202320:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/16/202320:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202307:15EDGAR2Form 8-K - Current report
8/10/202306:30PRNUSPalatin Initiates Clinical Program for Bremelanotide..
8/08/202307:00EDGAR2Form 8-K - Current report
8/08/202306:30PRNUSPalatin's Vyleesi® Licensee Fosun Pharma Reports First..

Your Recent History

Delayed Upgrade Clock